leisure time -WSS

leisure time

author：knowledge 2025-10-01 13:58:48 - browse：95

WASHINGTON — A veteran senator and champion of the biotech sector beat back an unusually strong challenge Tuesday night — thanks in large part to loyal support from the industry.

North Carolina Senator Richard Burr, a Republican who has long protected the bioscience companies that drive his state’s economy, overcame a surprisingly robust challenge from Democratic candidate Deborah K. Ross.

Burr, now finishing his second term in the Senate, serves on committees with oversight of both the Food and Drug Administration and Medicare and Medicaid. He is also chairman of the Select Committee on Intelligence.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： WHO recommends second malaria vaccine

WSS

Readout Newsletter: CAR

Some top drug companies are starting to take action on climate

The Karikó problem: Lessons for funding basic research

With Roe v Wade overturned, abortion providers work to adapt

Setback for rare diseases as Taysha Gene Therapies pulls back

Flu, Covid vaccination rates decline, new survey data show

entertainment

leisure time

Wikipedia

Virginia high school admissions case could be legal follow

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

How one medical school became remarkably diverse

The United States is paying nearly triple for new Covid vaccines

Activists slam private health insurers over coverage restrictions

What will Novo Nordisk's VC do with its influx of cash?

Guidelines to prevent youth baseball injuries need more muscle

Ebola: Gilead Sciences antiviral shows promise as new treatment

BioMarin wins approval for gene therapy to treat hemophilia A

HHS secretary Becerra pressed on Change HealthCare cyberattack

Wikipedia

CRISPR base editing slashes cholesterol levels in monkeys

Lawsuit highlights wrinkle for disputes over surprise medical bills

What will Novo Nordisk's VC do with its influx of cash?

How to save health care price transparency rules

Why depression after traumatic brain injury is distinct

IVG is promising — but it won’t replace IVF quite yet

entertainment

explore

entertainment

entertainment